Crystal chemistry of sibutramine: Thermal, diffractometric and spectroscopic characterization

Journal of Pharmaceutical Sciences

Volumn 97, Issue 12, 2008, Pages 5229-5239

  Maccaroni, Elisabetta ^a   Alberti, Enrica ^a   Malpezzi, Luciana ^b   Masciocchi, Norberto ^a   Pellegatta, Cesare ^c  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b POLITECNICO DI MILANO   (Italy)

^c SOLMAG SPA   (Italy)

Author keywords

Crystal and molecular structure; Powder diffraction; Sibutramine; Solid state NMR

Indexed keywords

SIBUTRAMINE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CRYSTAL; CRYSTAL STRUCTURE; DRUG SYNTHESIS; THERMOSTABILITY; X RAY POWDER DIFFRACTION;

EID: 57249098875     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21387     Document Type: Article

References (27)

1. Kiyoharu Ukai S, Chiharu Masuda M, Satoko Kubo O, Teruo Mukai J, Terutake Nakagawa O. 1990. Use of N,N-dimethyl-1-[1-(4-chlorophenyl)-cyclobutyl]-3- methylbutylamine. US patent No 4,939,175.
2. Kozlik A, Wilmshurst EC, Jefferey JE. 1982. Therapeutic agents. GB patent No 2,098,602.
3. McNeely W, Goa KL. 1998. Sibutramine: A review of its contribution to the management of obesity. Drugs 56:1093-1124.
4. Walter MW. 2005. Monoamine reuptake inhibitors: Highlights of recent research development. Drug Dev Res 65:97-118.
5. Ioannides-Demos LL, Proietto J, McNeil JJ. 2005. Pharmacotherapy for obesity. Drugs 65:1391-1418.
6. Rao DR, Kankan RN. 2004. Sibutramine free base in crystalline form and its pharmaceutical use. WO2004/099119.
7. Edward JJ, Derek WN. 1987. N-dimethyl-1-1-(4-chlorophenyl)cyclobutyl-3- methylbutylamine salt. GB patent No 2,184,122.
8. Kang T-W, Jeon K-F, Shon H-J, Choi W-K, Chang K-Y, Jin K-Y, Lee K-S. 2006. Anhydrous sibutramine malates and preparation method thereof. WO2006090999.
9. Lee J-H, Park G-S, Lee J-C, Kim H-K, Chang Y-K, Lee G-S. 2004. Pharmaceutical composition comprosing crystalline sibutramine methanesulfonate hemihydrate. WO2004/030663.
10. 2O. Z. Kristallogr 220:513-514.
11. Fang QK, Senanayake CH, Han Z, Morency C, Grover P, Malone RE, Wald SA, Cameron TS. 1999. First preparation of enantiomerically pure sibutramine and its major metabolite, and determination of their absolute configuration by single crystal X-ray analysis. Tetrahedron Asymmetry 10:4477-4480.
12. Han Z, Krishnamurthy D, Pflum D, Fan QK, Butler H, Cameron TS, Wald SA, Senanayake CH. 2002. First practical synthesis of enantiomerically pure (R)- and (S)-desmethylsibutramine (DMS) and unambiguous determination of their absolute configuration by single crystal X-ray analysis. Tetrahedron Asymmetry 13:107-109.
13. Lu BZ, Senanayake C, Li N, Han Z, Bakale RP, Wald SA. 2005. Control of Diastereoselectivity by solvent effects in the addition of Grignard reagents to enantiopure t-butylsulfinimide: Syntheses of the stereoisomers of the hydroxyl derivatives of sibutramine. Org Lett 7:2599-2602.
14. Sheldrick G. 1997. SHELXL-97 Program for Crystal Structure Refinement. Germany: Göttingen.
15. Coelho AA. 2003. TOPAS Version 3.1. Bruker AXS GmbH. Germany: Karlsruhe.
16. Given that the supplied material is racemic, the most obvious space group assignment was P-1. Actually, powders of S could as well be a conglomerate of P1 enantiomorphic forms, each one containing two homochiral crystallographically independent molecules, Z′ = 2, but this was excluded by successful structure solution in P-1.
17. 2Fg. J Solid State Chem 98:151-158.
18. Rietveld HM, 1969. A profile refinement method for nuclear and magnetic structures. J Appl Cryst 2:65-71.
19. Jeffery JE, Kerrigan F, Miller TK, Smith GJ, Tometzki GB. 1996. Synthesis of sibutramine, a novel cyclobutylalkylamine useful in the treatment of obesity, and its major human metabolites. J Chem Soc Perkin Trans 1:2583-2590.
20. Lai K-C, Liu Y-C, Tseng M-C, Lin Y-L, Lin J-H. 2007. Isolation and identification of a sibutramine analogue in a healthy food for weight loss. J Food Drug Anal 15:20-24.
21. Eufri D, Sironi A. 1989. SMILE-Shaded molecular imaging on low-cost Equipment. J Mol Graph 7:165-169, 158.
22. IUPAC. 1976. Commission on Nomenclature of Organic Chemistry, Section E: Stereochemistry (Recommendations 1974). Pure Appl Chem 45:11-30.
23. 3, Z = 8.
24. Fantin G, Fogagnolo M, Bortolini O, Masciocchi N, Galli S, Sironi A. 2003. Polymorphism of dehydrocholic acid: Crystal structure of the β-phase and guest-mediated solid phase conversion. New J Chem 27:1794.
25. Malpezzi L, Grato AM, Masciocchi N, Sironi A. 2005. Single crystal and powder diffraction characterization of three polymorphic forms of Acitretin. J Pharm Sci 94:1067-1078.
26. Maccaroni E, Alberti E, Malpezzi L, Masciocchi N, Vladiskovic C. 2008. Polymorphism of linezolid: A combined single-crystal, powder diffraction and NMR study. Int J Pharm 351:144-151.
27. Masciocchi N, Sironi A. 2005. Structural powder diffraction characterization of organometallic species: The role of complementary information. CR Chimie 8:1617-1630.